Aeroallergens from trees, grasses, mold, dust, and others can produce symptoms that range from minor to severe in affected individuals. Our 36 Inhalant IgE Panel assesses antibody response to 33 airborne allergens, providing helpful information for effective allergy management.
We run our IgE panels on a sophisticated FDA-approved immunoassay analyzer that utilizes enzyme-amplified chemiluminescence technology and can be run utilizing either serum or dried blood spot card samples.
Our 36-Inhalant IgE Panel is a quantitative ELISA analysis of specific IgE antibodies to 36 common inhalants.
Specimens are tested in duplicate on ELISA platform. We follow a diligent process to extract the key component from each analyte to ensure the antibody present in the patients’ serum will bind to it, and validate with positive and negative controls. The IgE antibodies, once bound to the antigen, are detected through spectrophotometric analysis wherein the values are directly proportional to the concentration of the analytes in the sample.